Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells.
about
Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Silencing activating transcrip ...... epatocellular carcinoma cells.
@en
Silencing activating transcrip ...... epatocellular carcinoma cells.
@nl
type
label
Silencing activating transcrip ...... epatocellular carcinoma cells.
@en
Silencing activating transcrip ...... epatocellular carcinoma cells.
@nl
prefLabel
Silencing activating transcrip ...... epatocellular carcinoma cells.
@en
Silencing activating transcrip ...... epatocellular carcinoma cells.
@nl
P2093
P2860
P356
P1476
Silencing activating transcrip ...... epatocellular carcinoma cells.
@en
P2093
Laibang Luo
Lifang Luo
Lijing Cai
Xiaohui Meng
Zhimou Tang
P2860
P304
P356
10.3892/MMR.2018.8921
P577
2018-04-23T00:00:00Z